Stock listing

Hua Medicine Ltd.

Selected listing: 2552 · HKEX · HKD · HK

Hua Medicine Ltd. (HKEX:2552), Health Technology. Latest release Aug 22, 2026: Hua Medicine Announces 2026 Interim Results.

2552:HKEXHKDHKUpdated October 2, 2026
Hua Medicine Ltd. logo
Ticker
HKEX:2552
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
HKEX
Currency
HKD

About Hua Medicine Ltd.

Hua Medicine Ltd. is a public company listed on the Hong Kong stock exchange under the ticker 2552. Hua Medicine focuses on developing innovative therapies for diabetes and related metabolic disorders.

Latest news from Hua Medicine Ltd.

Hua Medicine Announces 2026 Interim Results

August 22, 2026

Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China

March 3, 2026

Hua Medicine Announces 2025 Interim Results

August 28, 2025

Hua Medicine Announces 2024 Annual Results

March 28, 2025

Hua Medicine’s Leadership in Diabetes Treatment Recognized: CEO Dr. Li CHEN Awarded Prestigious C.C. Tan Life Science Industrialization Award

November 4, 2024

All Hua Medicine Ltd. news →

Research Hua Medicine Ltd.

Hua Medicine Ltd. company profile

View the public company page for Hua Medicine Ltd. on 6ix.

Hua Medicine Ltd. news

Read company news and market updates connected to Hua Medicine Ltd..

Hua Medicine Ltd. investor events

Find investor webinars, events, and replay context for Hua Medicine Ltd..

Alternate listings

HUMDF:OTC

US · USD

Alternate listing for Hua Medicine Ltd.; the primary context on this page is 2552:HKEX.